Live from the NIH registry
Studies recruiting near Dallas right now
Top 25 of 1,887 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Dallas, Texas (2.4 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Prostate Cancer, Prostate Adenocarcinoma
Phase 2
Interventional 90 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: University of Chicago
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Sarah Cannon Research Institute at Mary Crowley — Dallas, Texas (2.4 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Medical City Dallas Hospital — Dallas, Texas (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
Leadership Training Affect Physician Career Satisfaction
Leadership, Personality
N/A
Interventional 200 participants sought
Clinical Research Institute at Methodist Health System — Dallas, Texas (2.4 mi)
· Sponsor: Methodist Health System
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
UT Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: Pacific Edge Limited
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
Texas Oncology — Dallas, Texas (2.4 mi)
· Sponsor: Acepodia Biotech, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Texas Oncology - DFW — Dallas, Texas (2.4 mi)
· Sponsor: SCRI Development Innovations, LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Texas Oncology DFW — Dallas, Texas (2.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Dallas, Texas (2.4 mi)
· Sponsor: Dren Bio
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Niemann-Pick Type C Disease, GM1 Gangliosidosis
Phase 3
Interventional 147 participants sought
Children's Medical Center Dallas — Dallas, Texas (2.4 mi)
· Sponsor: Azafaros B.V.
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Modern Research Associates, PLLC — Dallas, Texas (2.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Muscular Atrophy, Spinal
Phase 3
Interventional 30 participants sought
Neurology Rare Disease Center — Flower Mound, Texas (24.5 mi)
· Sponsor: Biogen
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Dallas — Dallas, Texas (2.4 mi)
· Sponsor: RAI Services Company
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Baylor Scott and White Research Institute (Adults only) — Dallas, Texas (2.4 mi)
· Sponsor: Pierre Fabre Medicament
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
Physical Inactivity, Phosphate Overload
N/A
Interventional 124 participants sought
University of Texas Southwestern — Dallas, Texas (2.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
Paralysis; Quadriplegic, Quadraplegia
N/A
Interventional 2 participants sought
UT Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: Nader Pouratian
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: OncoNano Medicine, Inc.
Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy
Coronary Artery Disease, Coronary Artery Bypass Graft (CABG)
N/A
Observational 15 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Dallas, TX — Dallas, Texas (2.4 mi)
· Sponsor: Mediar Therapeutics
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer
Phase 1
Interventional 572 participants sought
NEXT Dallas — Irving, Texas (10.7 mi)
· Sponsor: ArriVent BioPharma, Inc.
tAN for First Responders
Mental Fatigue, Mental Stress
N/A
Interventional 30 participants sought
Spark Biomedical - DECENTRALIZED STUDY — Dallas, Texas (2.4 mi)
· Sponsor: Spark Biomedical, Inc.
Teen Recovery Through Inspiration, Support, and Empowerment
Suicidal Ideation, Suicide Attempt
N/A
Interventional 40 participants sought
The University of Texas Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Tekton Research — McKinney, Texas (29.3 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Texas Dermatology Research Center — Dallas, Texas (2.4 mi)
· Sponsor: Takeda